Madrigal Pharmaceuticals, Inc.

NISA INVESTMENT ADVISORS, LLC MDGL

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/15/2026

Shares

429

Value ($000)

250

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/15/2026	250	0.0%	429	12/31/2025
2025 Q3	10/23/2025	200	0.0%	435	9/30/2025
2025 Q2	7/31/2025	81	0.0%	267	6/30/2025
2025 Q1	4/30/2025	80	0.0%	241	3/31/2025
2024 Q4	1/17/2025	74	0.0%	240	12/31/2024
2024 Q3	10/24/2024	45	0.0%	211	9/30/2024
2024 Q2	7/19/2024	40	0.0%	143	6/30/2024
2024 Q1	5/2/2024	34	0.0%	129	3/31/2024
2023 Q4	1/25/2024	27	0.0%	116	12/31/2023
2023 Q3	11/2/2023	30	0.0%	206	9/30/2023
2023 Q2	8/11/2023	27	0.0%	116	6/30/2023
2023 Q1	5/2/2023	57	0.0%	236	3/31/2023
2022 Q4	2/2/2023	28	0.0%	96	12/31/2022
2022 Q3	11/7/2022	7	0.0%	96	9/30/2022
2022 Q2	8/3/2022	15	0.0%	213	6/30/2022
2022 Q1	4/29/2022	32	0.0%	328	3/31/2022
2021 Q4	2/3/2022	102	0.0%	1,775	12/31/2021
2021 Q3	10/18/2021	227	0.0%	2,842	9/30/2021
2021 Q2	8/6/2021	277	0.0%	2,845	6/30/2021
2021 Q1	4/26/2021	368	0.0%	3,145	3/31/2021
2020 Q4	1/25/2021	350	0.0%	3,145	12/31/2020
2020 Q3	10/20/2020	287	0.0%	2,417	9/30/2020
2020 Q2	7/27/2020	485	0.0%	4,281	6/30/2020